S1 Organizing Committee Prof. Dr. M.D. De Jong, Chair Prof. Dr. A.J.W. Van Alphen Prof. Dr. W. Bitter Prof. Dr. S. Brul Prof. Dr
Total Page:16
File Type:pdf, Size:1020Kb
Organizing committee Poster committee Prof. dr. M.D. de Jong, chair Prof. dr. S. Brul Prof. dr. A.J.W. van Alphen Dr. W. van Schaik Prof. dr. W. Bitter Dr. A.M.J. Wensing Prof. dr. S. Brul Prof. dr. L. Dijkhuizen Dr. B. Duim Dr. J.W.B. van der Giessen Dr. P.J.A. Haas Prof. dr. ir. M.S.M. Jetten Prof. dr. M.P.G. Koopmans Prof. dr. O.P. Kuipers Prof. dr. P. Rottier Prof. dr. P.H.M. Savelkoul Dr. B.J.M. Vlaminckx Prof. dr. ir. M.H. Zwietering The Scientific spring meeting is organized by the Dutch Society of Medical Microbiology (NVMM) and the Royal Dutch Society of Microbiology (KNVM). Meeting secretariat Congress Company P.O. Box 2428 5202 CK ’s-Hertogenbosch Tel 073 - 700 35 00 [email protected] www.congresscompany.com Ned Tijdschr Med Microbiol 2013;21:Supplement S1 PROGRAMME Tuesday ApriL 16, 2013 eXHiBiTiON ROOM ATHeNe B/C ROOM ATHeNe A ROOM 2 ROOM 4/5 ROOM 6/7 ROOM 8/9 09:00 - 09:30 Registration 09:30 - 11:00 Plenary session 11:00 - 11:30 Coffee/tea 11:30 - 12:45 Plenary session & Award Ceremony 12:45 - 14:00 Lunch KNVM Business Meeting 14:00 - 15:30 New challenges in Community acquired Leishmaniasis: a intestinal microbes Microbial pathogenesis 1 Clinical microbiology infection prevention Clostridium difficile curable disease? and host interplay WAMM: Back to the infections: from pigs to roots - diagnostics of humans and vice versa urinary tract infections 15:30 - 16:00 Coffee/tea S2 16:00 - 17:30 Clinical microbiology Bacterial cell growth Campylobacter – Clinical development Highly resistant micro- STD dynamics in host interactions of malaria drugs organisms outside the the Netherlands and and vaccines in the hospital - What can we europe Netherlands expect from nursing homes and public health services? 17:30 - 18:30 Drinks 18:30 - 20:30 Dinner 20:30 - 22:15 Poster session & Poster award ceremony 22:15 - 01:30 Party PROGRAMME Wednesday ApriL 17, 2013 eXHiBiTiON ROOM ATHeNe B/C ROOM ATHeNe A ROOM 2 ROOM 4/5 ROOM 6/7 ROOM 8/9 08:30 - 09:00 Registration 09:00 - 10:30 Viral zoonoses Whole genome Antimicrobial NVMy symposium 1: New human and Finding the needle sequencing in clinical peptides: a rich Detection and veterinary vaccines against in the haystack: microbiology and its appli- source for developing diagnosis tuberculosis molecular diagnostics cations in understanding novel antibiotics of gastro enteritis microbial biology 10:30 - 11:00 Coffee/tea 11:00 - 12:30 NVMy symposium 2: Virology Microbial physiology Computer assisted experimental evolution Microbial patho- epidemiology and teaching genesis 2 treatment 12:30 - 14:00 Lunch 13:00 - 14:00 BBC-MMO Business S3 Meeting 14:00 - 15:30 WMDi: Novel Antimicrobial resistance Horen, zien en Travel-related Genome-associated Progress in approaches in the vooral niet zwijgen diseases biomarkers for vaccines microbiology detection of antimi- (NL-talige sessie) crobial resistance 15:30 - 16:00 Coffee/tea 16:00 - 17:30 NVMM Business Meeting Ned Tijdschr Med Microbiol 2013;21:Supplement Ned Tijdschr Med Microbiol 2013;21:Supplement FLOORPLAN PAPENDAL EXHIBITION ROOMS Ned Tijdschr Med Microbiol 2013;21:Supplement Ned Tijdschr Med Microbiol 2013;21:Supplement S4 S5 Major Sponsor SCIENTIFIC PROGRAMMA MONDAY 15 APRIL 2013 15:00 - 15:30 Infection risks in hospitals: it’s the environment stupid! O006 Jan van Zeijl Room Athene A 13:00 - 17:15 National examination for medical microbiolo- gists in training Athene A Community acquired Clostridium difficile infections: from pigs to humans and vice versa Chair: Ed Kuijper SPONSORS AND EXHIBITORS Restaurant 14:00 - 14:30 Clostridium difficile infections outside 19:00 - 21:00 Dinner healthcare facilities in Denmark O007 Katharina Olsen (Denmark) TUESDAY 16 APRIL 2013 Abbott Diagnostics iTK Diagnostics 14:30 - 14:45 Clostridium difficile 078 in pigs, a threat for Alere Health Labolutions farmers and employees ApDia Luminex 09:00 - 09:30 Registration O008 Liny Keessen Astellas Pharma Mediaproducts 14:45 - 15:00 Whole-genome sequencing reveals potential Bactimm Mediphos Medical Supplies 09:30 - 11:00 Plenary session interspecies transmission of Clostridium difficile type 078 Baseclear Merck Sharp & Dohme O009 Wilco Knetsch Becton Dickinson Meridian Bioscience Athene B/C Chair: Oscar Kuipers 15:00 - 15:15 Outbreaks of Clostridium difficile type 027 Beldico Minigrip Nederland 09:30 - 10:15 c-di-AMP, an essential signaling nucleotide in infections in nursing homes; tip of the iceberg? Gram-positive bacteria Bio Rad Laboratories MiPS O010 Sofie van Dorp Bio Trading Benelux MLS O001 Prof. Jörg Stülke, institut für Mikrobiologie und Genetik, Göttingen, Germany 15:15 - 15:30 Micro-array analysis and phenotypic character- Biognost MP Products ization of Clostridium difficile cell membrane BioMerieux Benelux Nimagen 10:15 - 11:00 From antigenic variation to base J in protease knock-out strains: reveals a possible trypanosomatids link to virulence Bodégro Novaveth O002 Prof. Piet Borst, NKi, Amsterdam O011 Dennis Bakker Boom Oxoid Bruker Nederland Panasonic Biomedical Sales europe 11:00 - 11:30 Coffee/tea break Room 2 Leishmaniasis: a curable disease? Cepheid Benelux Perkinelmer Chair: Titia Kortbeek Check-Points Pfizer 11:30 - 12:45 Plenary session & award ceremony Clindia Benelux Qiagen Benelux 14:00 - 14:30 Asymptomatic carriers in visceral leishmaniasis Diagenode Diagnostics R-Biopharm AG O012 epco Hasker (Belgium) DiaSorin Roche Diagnostics Nederland Athene B/C Chair: Menno de Jong 14:30 - 15:00 Effectiveness of treatment of visceral elitech Benelux ServiceXS 11:30 - 12:15 Host switches and evolution: news from viral reservoir investigations leishmaniasis eppendorf Nederland Siemens Healthcare Diagnostics O003 Prof. Christian Drosten, institute of O013 Koert Ritmeijer Gilead Sciences Netherlands Softmedex Solutions Virology – university of Bonn Medical Centre, 15:00 - 15:15 Therapy for leishmaniasis in returning Greiner Bio-One Technologiestichting STW Bonn, Germany travellers Hettich Benelux unilever Vlaardingen 12:15 - 12:45 Award ceremony O014 Caspar Hodiamont Hologic Netherlands 15:15 - 15:30 Leishmaniasis in the Netherlands 2005-2012: 12:45 - 14:00 Lunch epidemiology, diagnostic techniques and sequence-based species typing in 192 patients O015 Aldert Bart Athene A 13:00 - 14:00 NVvM Business meeting Room 4/5 Intestinal microbes and host interplay Chairs: Peter van Baarlen & Clara Belzer 14:00 - 15:30 Parallel sessions 14:00 - 14:30 Adaptive immunity, microbiota composition and prevention of pathobiont outgrowth in Athene B/C New challenges in infection prevention zebrafish Chair: Greet Vos O016 Sylvia Brugman 14:00 - 14:30 A nosocomial outbreak of VIM-positive 14:30 - 15:00 The gut microbiome using metagenomics and Pseudomonas aeruginosa: problems and dedicated bioinformatics pitfalls O017 Jeroen Raes O004 Juliette Severin 15:00 - 15:15 The effect of viral, bacterial and parasitic 14:30 - 15:00 From guidelines to implementation: do we pathogens on the intestinal microbiota need fasces? O018 Dries Budding O005 Jan Kluytmans Ned Tijdschr Med Microbiol 2013;21:Supplement Ned Tijdschr Med Microbiol 2013;21:Supplement S6 S7 15:15 - 15:30 Streptococcus suis interaction with human 16:15 - 16:30 Molecular epidemiology of an epidemic rise of 16:00 - 16:30 Dutch contribution to malaria vaccine and O058 Tanja Geelen intestinal epithelial cells vancomycin-resistant Enterococcus faecium in novel drug development the Netherlands O019 Maria Laura Ferrando O045 Robert Sauerwein Room Sydney O032 Jan Sinnige 16:30 - 16:45 Preclinical development of genetically attenuated 17:30 - 18:30 Drinks 16:30 - 16:45 Yersinia pseudotuberculosis as cause of terminal malaria parasites for vaccine development Room 6/7 Microbial pathogenesis 1 ileitis without diarrhea in three patients O046 Shahid Khan Chair: Pieter-Jan Haas O033 Herman Wunderink Restaurant 16:45 - 17:00 Preclinical development of malaria drugs 14:00 - 14:15 The Staphylococcal Panton-Valentine 16:45 - 17:00 Identification of a new biomarker for fast against liver stages 18:30 - 20:30 Dinner Leukocidin targets C5a receptors discrimination between epidemic V. cholerae O047 Clemens Kocken O020 András Spaan O1/O139 and non-epidemic V. cholerae in a 17:00 - 17:15 Efficacy and safety of ivermectin to prevent Foyer 14:15 - 14:30 Pneumococcal meningitis: heterogenous modified MALDI-TOF MS assay malaria transmission after treatment of receptor expression and the influence on O034 Armand Paauw 20:30 - 22:00 Poster session Plasmodium falciparum infections with Streptococcus pneumoniae interaction with 17:00 - 17:15 Airway microbiome in Cystic Fibrosis patients: artemether-lumefantrine: a double-blind 22:00 - 22:15 Poster award ceremony the blood-brain barrier exploring culturing bias randomized controlled clinical trial O021 Federico iovino O035 Jorrit Jan Hofstra O048 Guido Bastiaens Athene A 14:30 - 14:45 Staphylococcus aureus secretes extracellular 17:15 - 17:30 Urinary antigen test established pneumococcal 17:15 - 17:30 Complete protection against malaria after adherence proteins that block neutrophil 22:15 - 01:30 Party pneumonia has same outcome as bacteraemic sporozoite immunization of volunteers under serine proteases (NSPs) pneumococcal pneumonia chloroquine prophylaxis is mediated by O022 Daphne Stapels O036 Suzan van Mens pre-erythrocytic immunity WEDNESDAY 17 APRIL 2013 14:45 - 15:00 Distinct localization and assembly of O049 else Bijker complement C5b-9 on gram-positive bacteria Athene A Bacterial cell growth 08:30 - 09:00 Registration O023 evelien Berends Chair: Eefjan Breukink Room 6/7 Highly